To include your compound in the COVID-19 Resource Center, submit it here.

PEP005 topical ingenol mebutate gel: Additional Phase III data

Additional data from the double-blind, U.S. Phase III REGION-Ib trial in 203 patients showed that a 0.05% concentration

Read the full 189 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE